For decades, flies have been a model for innate immunity. In this issue of Cell, Tassetto et al. describe a mechanism for antiviral RNAi spreading that parallels mammalian adaptive immunity through reverse-transcribed vDNA circles and the systemic dissemination of small-RNA-containing exosomes.
At times, homology between invertebrate and mammalian immune signaling pathways can be strikingly similar. Discoveries in Drosophila, notably the discovery of the role of Toll in immunity, have paved the way for entire fields of research in mammalian innate immunity.
However, some clear differences in immune strategies exist between invertebrates and mammals. Whereas mammals have a complex, protein-based antiviral immune response featuring both innate and adaptive effectors, insects rely on a robust, sequence-specific, RNA interference response for antiviral defense. These findings have led to the search for RNAi-based immune functions in mammals (MacKay et al., 2014) and, conversely, for protein-based antiviral effectors in invertebrates (Buchon et al., 2014; Kranzusch et al., 2015) . Perhaps the most glaring difference is that Drosophila lack an adaptive immune system and rely solely on innate immunity for protection against pathogens. Descriptions of immune priming in Drosophila, resulting in a stronger specific immune response upon secondary infection, have been described using Streptococcus pneumoniae and Beauveria bassina (Pham et al., 2007) .
However, priming was not universally observed with all species of bacteria. This response was termed priming rather than memory, as it did not require receptor rearrangement. But is receptor rearrangement a necessary requirement for a heightened, protective response upon secondary challenge in order to be considered an adaptive immune response?
What are the features of an adaptive immune response? An adaptive immune response is pathogen specific, non-germline encoded, immune cell mediated, long lasting, and amplified in response to secondary infection. In this issue, Tassetto et al. (2017) challenge the notion that flies lack adaptive immunity. The authors describe a novel mechanism of RNAi amplification and dissemination in which a subset of immune cells are able to amplify siRNAs from non-germline-encoded DNA, stably package them, and spread them to distal sites, providing protection to naive cells-very similar to an adaptive response. How or whether Drosophila are able to provide systemic antiviral immunity has been a lingering question. While siRNA is the dominant means of antiviral protection, mechanisms for its amplification and its ability to spread from an infected cell to protect distal naive cells have remained elusive. One hypothesis is that flies, like nematodes and plants, are able to copy and spread RNAi. Plants and nematodes utilize RNA-dependent RNA polymerases (RdRps) to spread and amplify RNAi, but flies lack RdRps. Yet, siRNAs manage to spread to distal sites within the fly, arguing that a mechanism for RNAi spreading does exist (Saleh et al., 2009) . In this issue, Tassetto et al. identify a mechanism for siRNA amplification and dissemination.
Operating under the assumption that the amplified secondary viral siRNAs (vsRNAs) will have a 5 0 triphosphate group because they would be generated by de novo transcription, the authors developed a novel method of small RNA sequencing to detect such small RNAs. Using this method, small RNAs are treated with phosphatase to convert the triphosphate group of any hypothetically amplified vsRNAs to a monophosphate group and are then processed for next-generation sequencing as in standard protocols. This modification allowed the authors to unveil a novel RNAi population, present after viral infection and enriched for viral sequences.
Drosophila haemocytes are a circulating population of blood cells that phagocytose, produce antimicrobial peptides, and are capable of taking up dsRNA to produce functional siRNAs. In vitro, haemocyte-like cell lines produce circular copies of viral-derived DNA (vDNA) after RNA virus infection through a reverse-transcriptase-dependent mechanism (Goic et al., 2013) . Here, haemocytes produce circular vDNAs to serve as a template for the amplification of secondary vsRNAs in vivo, and vDNA production is dependent upon Ago2. vsRNAs are then packaged into exosome-like vesicles (ELVs) and are released from haemocytes to spread protective vsRNAs to distal sites. These are then processed into siRNAs and loaded into functional RISCs. Notably, the authors also show that these exosomes can confer passive immunity. Exosomes purified from Sindbis-virus-infected flies prevented viral replication when injected into naive animals. This protection was both pathogen specific and long lasting.
Overall, these results demonstrate the production of long-lasting effector cells, haemocytes, containing non-germlineencoded DNA to produce immune effectors, the small-RNAi-containing ELVs.
This system parallels the role of B cells in mammalian immunity (see Figure 1) . As with any discovery, this novel mechanism of long-lasting adaptive immunity in flies leaves us with a new set of unresolved Upon primary infection, both flies and mammals utilize non-germline-encoded DNA to produce soluble immune effectors. In flies, vDNA is derived from dsRNA intermediates produced during infection and engulfed by circulating haemocytes. In mammals, B cells activate class switch recombination to produce novel circulated antibodies. Immune effectors are then disseminated to provide long-lasting protection. In flies, vDNAs are used as templates for production of secondary viral siRNAs (vsRNAs), which are packaged into exosomes and excreted. In naive cells, these vsRNAs are loaded onto an RNA-induced silencing complex (RISCs) to provide protection. In mammals, antibodies are produced from plasma cells and provide protection through a variety of mechanisms.
with them? Is the antiviral response in flies completely RNAi mediated? Given the rapid mutation rate of RNA viruses, this seems like a poor host defense strategy, especially since viruses would simply need to encode a dsRNA-binding protein, which many do, to shut the entire immune response down. Undoubtedly, these questions will be the focus of future studies.
